Background and Aims: Ano-genital granulomatosis is a rare chronic granulomatous condition of the skin that causes lymphoedema of the external genitalia.
Introduction
Ano-genital granulomatosis [AGG] is a rare idiopathic chronic inflammatory condition that presents with progressive and persistent genital and perigenital oedema, and usually non-caseating granulomas are revealed on skin biopsy. 1 Although the condition was first formally described in the 1970s, 2 the medical literature has largely been limited to case reports and small case series. 1, [3] [4] [5] Reports have indicated a possible overlap with Crohn's disease [CD] . [6] [7] [8] [9] The condition usually manifests as chronic penile, scrotal, vulval or perianal oedema but may affect the more extensive perigenital area including the mons pubis, buttocks and natal cleft. Episodes of secondary cellulitis occur frequently, as with many other forms of lymphoedema. 10 Histology from affected skin typically demonstrates the presence of non-caseating granulomas and a chronic inflammatory infiltrate, although granulomas may be sparse and easily missed. The underlying aetiology is not clearly understood, but a variety of both infective and inflammatory conditions have previously been associated with this condition including sarcoid, Behcet's, Wegener's granulomatosis, tuberculosis, and syphilis. 1 Where AGG and CD co-exist, genital lymphoedema may result from the direct extension of ano-rectal CD into the affected skin, but equally can occur without contiguity between skin and gastrointestinal tract. 11 Impaired lymphatic drainage has previously been implicated in the pathogenesis of CD. 12 Histopathological changes similar to those that occur in AGG have been described in intestinal Crohn's disease, which may explain the observed overlap seen between these conditions. 13 Little is known about the optimal management of AGG, but the use of antibiotics, corticosteroids, and tumour necrosis factor inhibitors [aTNF] in the management of AGG have all been described in case reports. 11, [14] [15] [16] A recent case series has reported the clinical features of vulval lymphoedema in 22 females with and without CD. 16 We therefore aimed to characterise the clinical features, histological findings, response to treatment, and overlap with CD in a cohort of 25 male patients with a confirmed diagnosis of AGG, presenting with genital swelling to a national lymphoedema unit.
Methods
This was a retrospective descriptive case series. Patients with genital lymphoedema and a suspected diagnosis of AGG were referred to our centre where they were reviewed in the joint gastroenterology and lymphoedema clinic. Initial evaluation included a full clinical history, a detailed physical examination, and assessment of the pattern of genital [and perigenital] lymphoedema. After acquiring full patient consent, digital photographic images were made of the extent of genital oedema, as a reference to assess treatment response. Samples for histological diagnosis were taken at the first clinic assessment, usually with a punch biopsy under local anaesthetic. Histology was reported by two specialist histopathologists. All potential cases of the condition were discussed by the gastroenterology-lymphoedema team at a multidisciplinary team meeting, and agreed cases of AGG were collated in a database.
Clinical-pathological data were collected retrospectively [CA and RM] for this study. The clinical notes, letters, electronic records, and histology were retrospectively reviewed for each confirmed case of AGG. Co-existent medical conditions were ascertained from historical clinical records and/or confirmation with the patient. Details of medical and surgical treatments were obtained by casenote review.
Results

Demographics
We identified 25 
Clinical presentation
The commonest anatomical sites for oedema were the penis [92% of patients], and scrotum [80%]. Figure 1 demonstrates the characteristic lymphoedematous appearance of the external male genitalia in two patients suffering from AGG, one of whom also had intestinal CD. The combination of penile and scrotal involvement was seen in 80% of patients. Table 2 shows the respective areas of anatomical involvement in AGG patients with and without CD. Ulceration and fissuring were not common presenting features in these patients.
All patients described a chronic progressive disease pattern characterised by relapsing and remitting periods of increased genital lymphoedema, interspersed with periods of erythema, resulting from secondary cellulitis. Patients also frequently described problems with urinary flow and difficulties with sexual intercourse.
Comorbidities
A total of 13 patients [52%] had other medical diagnoses at the time of AGG diagnosis. Additional comorbidities are reported on 
Histology
Full histology was available for 22 patients [88%]. Two patients had biopsy and histology assessed at the referring hospital and found to be consistent with AGG. One patient refused genital biopsy, but it was agreed that his clinical presentation was consistent with a diagnosis of AGG. Table 3 categorises the frequency of the histological findings associated with AGG. All samples contained a lymphocytic predominant chronic inflammatory infiltrate; 57% of the biopsies contained identifiable non-caseating granulomas; and 14% contained intralymphatic granulomas. Figure 2 demonstrates some of the pertinent histological findings associated with AGG.
Management and treatment response
The medical treatments and the proportion of patients reporting response in AGG symptoms are summarised in Figure 3. 
Supportive therapy
All patients were referred to lymphoedema clinical nurse specialists and received compression garments and instructions on penile bandaging in cases of severe penile lymphoedema, although standard lymphoedema treatment had limited efficacy without addressing the underlying inflammatory component of the disease process.
Oral antibiotics
Antibacterial agents were used in 84% of patients. They were predominantly prescribed as long term prophylaxis [1-6 months] to prevent episodes of secondary cellulitis; 76% of patients reported an improvement in their AGG symptoms with antibiotic use. Prophylactic antibiotics used included: doxycycline 100 mg OD, co-trimoxazole 960 mg OD, co-trimoxazole 480 mg BD, co-amoxiclav 375 mg TDS, clindamycin 250 mg OD, and trimethoprim 200 mg OD.
Oral corticosteroids
Oral steroid therapy was used in 72% of the patients [usually in combination with antibiotics], with 72% of patients treated showing initial improvement in lymphoedema, although relapse on tapering the doses was common. Prescription data were available for 11 patients receiving 12 reducing courses of prednisolone. Mean starting prednisolone dose was 34.1 mg [range 20-50 mg]. Dose reduction intervals were generally between 7 and 14 days per drop in dosage. 
Immunomodulators
Tumour necrosis factor inhibitors [aTNF]
Anti-TNF therapy was used in six AGG patients, all of whom had a co-diagnosis of CD. Standard induction regimens were used for both infliximab and adalimumab. Four patients were treated with infliximab and two with adalimumab. A total of three patients gained benefit with reduction in genital lymphoedema.
Surgical therapies
Although surgery is not considered curative for AGG, it can be employed to reduce the volume of lymphoedema resulting from the underlying inflammatory changes. Indications for surgery included: failure of medical treatment, difficulties with micturition, difficulties with sexual intercourse, and cosmetic issues. Two main surgical techniques were used; circumcision [n = 6], of which 83% reported improvement in symptoms; or de-bulking surgery [n = 4], with all patients reporting initial improvement. The preferred surgical debulking procedure involves excision of lymphoedema tissue followed by split skin grafting and/or excision of excess scrotal tissue with primary closure. The mean time to surgery from AGG diagnosis was 13 months. No immediate post-surgical complications were reported in the four patients who underwent de-bulking. By approximately 1-2 years after de-bulking surgery, all four patients had minimal recurrence of penile oedema. One patient had redeveloped severe penile oedema by 4 years after surgery, and was being considered for a further de-bulking procedure.
Discussion
Key findings
To our knowledge, this is the largest study of male patients with AGG, 40% of whom were found to have intestinal CD. The majority of patients initially presented with chronic penile and scrotal oedema. There was often a protracted delay between first reported symptoms and formal diagnosis, approaching a mean of 5 years. Skin biopsy from affected areas revealed non-caseating granulomas in more than half of patients, and 14% had intralymphatic granulomas. All 25 patients reported a chronic progressive disease pattern characterised by recurring episodes of genital oedema with or without a secondary cellulitis. Almost three-quarters of patients experienced shortterm improvement with oral corticosteroid therapy, but most needed second-line treatment in the form of immunomodulators or aTNF therapy to achieve a sustained response.
Findings in relationship to other studies
In keeping with the findings of previous case reports, 40% of our cohort had both AGG and CD. In a review of previously reported cases of AGG, 36% of patients had concomitant CD. 1 It is important to recognise that AGG may precede the diagnosis of CD by many years, 17 but equally can manifest following confirmation of CD. In our series, half of patients were diagnosed with CD following their AGG diagnosis which in this respect resembles oro-facial granulomatosis [OFG] . 18 The considerable period between self-reported first symptoms and formal diagnosis seen in our cohort is similar to that reported in a case series of female patients with vulval Crohn's. 16 This presumably relates to clinicians' unfamiliarity with the condition, resulting in misdiagnosis and inappropriate specialist referral. Patient embarrassment may also be a contributing factor to delayed presentation. 19 Our study is confined to male patients with confirmed AGG, but we do not feel this is a distinct clinical entity exclusive to males. We have also managed female patients with this condition presenting with vulval oedema very much as described previously by Laftah et al., which this research group have defined as 'vulval Crohn's disease'. 16 Furthermore, in a summary of historical individual case reports and series, about 40% of patients with AGG were male. 1 The presence of non-caseating granulomas is a common finding in patients with AGG and was seen in more than half of our cohort. The occurrence of intralymphatic granulomas may represent a potential mechanism through which lymphatic drainage is impeded, leading to the genital lymphoedema and subsequent inflammation. 20 We found evidence to support this disease mechanism, with 14% and 52% of our biopsies showing intralymphatic granulomas and lymphatic dilatation, respectively. Intralymphatic granulomas and lymphangiectasia have also been described in OFG. 21 OFG is a rare clinical entity manifest by lymphoedema of the face and oral cavity, and shares many of the histological characteristics of AGG. 22 OFG is also reported to overlap with intestinal CD in 20-40% of cases. 18, 23 Notably in our series, four patients had OFG, two of whom had a triad of AGG, OFG, and CD. Impairment of lymphatic drainage in intestinal CD has also been linked to granulomatous obstruction of lymphatic flow, lymphangiectasia, and lymphangitis. 12, 13 In one study, 46% of granulomas found within biopsies taken from patients with intestinal CD were related to or in close proximity to lymphatic vessels. 24 These observations possibly point to a pathway common to the two clinical entities. Certainly, a role for lymphatic insufficiency in the aetiopathogenesis of CD has previously been proposed. 13, 25 The nomenclature is confusing and it has been argued by some authors that AGG is indistinguishable from cutaneous metastatic CD. 15 However, we propose that AGG and MCD are two separate presentations of cutaneous granulomatous inflammation as a result of CD. Metastatic Crohn's disease [MCD] is a rare cutaneous granulomatous disorder where patients present with pruritic erythematous plaques or nodules that are non-contiguous with the gastrointestinal tract, and separated from it by normal skin. MCD may affect the face, trunk and limbs, but may also affect genital skin. 26 Histological analysis of these lesions confirms the presence of a non-caseating granulomatous inflammatory infiltrate. 27 AGG may appear similar to MCD to some readers because of the reported presence of granuloma within the skin. We hypothesise that AGG is in fact a separate entity, based on three factors. First, the defining feature of AGG is the presence of swelling and lympoedema, which is not a feature of MCD. Second, AGG only affects the anogenital region, whereas MCD frequently affects non-genital skin. Finally, over 98% of patients with MCD have or will subsequently develop a co-diagnosis of CD, 28 whereas co-diagnosis in AGG is only approximately 40%.
Studies addressing optimal management of AGG are lacking. The use of antibiotics has been previously described in the management of AGG with mixed success. 11, 14, 16 In this case series, antibiotics were used frequently where secondary cellulitis was suspected, and as prophylaxis against further episodes. Infection, particularly cellulitis, is common in patients with AGG, probably as a direct result of impaired immune surveillance within regions of damaged lymphatic drainage. 10 Antibiotics are likely to be of benefit in acute flares where a secondary cellulitis may complicate the underlying granulomatous inflammation. Low-dose antibiotic prophylaxis may also be indicated, although its role in preventing disease progression is unknown, and it is plausible that recurrent cellulitis may cause irreversible lymphatic damage.
Oral corticosteroid therapy provided short-term benefit in our patients, often with initial improvement in oedema. Steroid treatment is usually ineffective in primary lymphoedema as the impaired lymphatic drainage occurs as a result of a genetically predetermined weakness within the lymphatic channels. However, the action of corticosteroids on the inflammatory component of AGG may explain their efficacy in this condition. The efficacy of corticosteroids in the long term is limited, since we have observed oedema frequently recurs on cessation of treatment.
Immunomodulators such as azathioprine [AZA] may have a role in the long-term treatment of AGG. They have established efficacy in the treatment of intestinal CD and are also used frequently in management of OFG. 23 In our series, clinical improvement was found in patients both with and without associated CD. Two-thirds of our cohort treated with AZA had symptomatic improvement. Laftah et al. reported similar response rates in a cohort of female patients with vulval CD. 16 Our experience with aTNF therapy was limited to six patients, all of whom had CD, and half of whom reported symptomatic improvement in AGG symptoms. Previous case reports have indicated response in patients with AGG, both with and without intestinal CD. 5, 16 
Conclusion
Ano-genital granulomatosis is a rare condition and usually presents with penile and scrotal lymphoedema in males. Unless the clinician is vigilant, there may be a protracted delay in diagnosis. In this largest case series, we have confirmed a strong association with Crohn's disease. Genital lymphoedema in association with gastrointestinal symptoms should prompt careful evaluation to exclude AGG and intestinal Crohn's disease. A variety of treatment options for AGG exist and many of the agents used in the management of Crohn's also appear effective in AGG. However, further studies are required to define optimal treatment in this condition.
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